Semaglutide has gained significant attention as an effective weight loss medication
Ivanievi M, Herman M, Horvatiek M, Vui Lovreni M, elmi J
Ozempic and Wegovy are also among the drugs selected for the next round of Medicare price negotiations under the Inflation Reduction Act, which President Joe Biden signed into law in 2022
On September 22, 2023, the FDA added a warning stating that semaglutide, the drug in Ozempic, has been reported to cause gastrointestinal disorders and bowel injuries
Acceptable evidence typically includes: A Certificate of Analysis (COA) from a qualified lab verifying identity, potency, impurities, and endotoxin levels